
Shanmuga Hospital Limited (BSE SME)
Feb 13, 2025 - Feb 17, 2025
Price | ₹54 - ₹54 |
Premium | ₹3 |
---|---|
Lot size | 2000 |
Allotment | Feb 18, 2025 |
Listing | Feb 21, 2025 |
Category | Lot(s) | Qty | Amount | Reserved |
---|---|---|---|---|
Retail | 1 | 2000 | 108000 | 907 |
HNI | 2 | 4000 | 216000 | 906 |
Last updated on 17-Feb-2025 18:52:02
Category | Offered | Applied | Times |
---|---|---|---|
HNIs | 1812000 | 1286000 | 0.71 |
Retail | 1814000 | 7994000 | 4.41 |
Total | 3626000 | 9280000 | 2.56 |
Total Applications: 6563 |
HNI Interest Cost Per Share (7 Days) | |||||
---|---|---|---|---|---|
@7% ₹0.1 | @8% ₹0.1 | @9% ₹0.1 | @10% ₹0.1 | @11% ₹0.1 | @12% ₹0.1 |
IPO Reservation
Category | Shares Offered | No. of Shares |
---|---|---|
Retail | 47.50% | 1814000 |
Other | 47.50% | 1812000 |
Market Maker | 5.00% | 192000 |
Total No. of Shares | 100% | 3818000 |
Shanmuga Hospital IPO Details
Issue Size | 38,18,000 shares (aggregating up to ₹20.62 Cr) |
Fresh Issue | 38,18,000 shares (aggregating up to ₹ 20.62 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 97,95,000 shares |
Share Holding Post Issue | 1,36,13,000 shares |
Market Maker Portion | 1,92,000 shares |
Market Maker | Black Fox Financial |
Key Performance Indicator
KPI | Sep-24 | Mar-24 | Mar-23 |
---|---|---|---|
ROE | 12.25% | 30.71% | 40.28% |
ROCE | 15.09% | 35.89% | 42.72% |
D/E | 0.5 | 0.53 | 0.65 |
RONW | 12.25% | 30.71% | 40.28% |
EPS (basic) | 2.44 | 5.37 | 4.9 |
P/E Pre IPO | 10.05 | ||
P/E Post IPO | 11.36 |
Company Financials In Crores
Period Ended | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Assets | 37 | 34 | 23 | 11 |
Revenue | 25 | 43 | 40 | 41 |
Profit After Tax | 3 | 5 | 5 | 7 |
Net Worth | 20 | 17 | 12 | 7 |
Reserves and Surplus | 10 | 7 | 12 | 7 |
Total Borrowing | 10 | 9 | 8 |
About Company
Strong Oncology Presence – Offers specialized cancer care with advanced treatment facilities, enhancing its reputation in the region.
Experienced Promoters – Backed by over four decades of healthcare expertise, ensuring strong leadership and strategic growth.
Affordable Healthcare – Provides cost-effective medical services, making quality treatment accessible to the regional population.
Legal Proceedings – Ongoing legal cases involving the company, directors, promoters, and group entities could negatively impact operations and financial stability if rulings are unfavorable.
Limited Operating History – With a short track record since 2020, investors may find it challenging to evaluate the company's long-term growth and financial performance.
Dependence on Healthcare Professionals – The hospital relies heavily on doctors and nurses, many on a consultancy basis, and any difficulty in attracting or retaining them could affect business operations and service quality.
Phone: 044 - 28140801 to 28140803
Email: smeipo@integratedindia.in
Website: https://www.integratedregistry.in/RegistrarsToSTA.aspx?OD=1